Tropoflex

Overview

1. Inflammation induces a cascade of enzymic activity that degrades collagen structure and tissue integrity. TropoFlex inhibits this inflammatory cascade and blocks the degradation of collagen, enabling regeneration to occur.

Funding and backers

Total raised
$250k
1 round on record
Latest round
$250k
Venture round · Sep 2025 · 13 mo ago
The money's age
Due for its next round
13 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 10, 2025 Raised a round Venture round $250k · SEC Form D 2025 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Sep 2025 $250k — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Tropoflex Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Paul CastellaExecutive Officer, DirectorSEC Form D
Similar startupsby what they do, their industry and backers
GeniPhysVenture round $3M · 9 mo ago · Founded 2021 · 11-50 employees
GeniPhys is developing and commercializing its patented Collymer ™ technology -a first-in-class polymerizable (scaffold-forming) collagen…
HyfacolVenture round · 15 mo ago · Founded 2023 · 11-50 employees
HyFaCol is a Collagen Manufacturing Platform which significantly improves the production and quality of medical grade collagen.
ElavateFounded 2022 · 51-200 employees · 9 roles
The All-In-One Multi Collagen blend, made locally in the UK, containing clinically effective doses of marine collagen and bovine collagen…
JellagenVenture round · 8 mo ago · Founded 2013 · 1-10 employees
Collagen-based innovation that addresses complex tissue engineering and regenerative medical needs, helping to shape next-generation…
CorefyFounded 2018 · 51-200 employees · 5 roles
Command your entire payment stack from one platform. Corefy connects 650+ providers, routes and cascades transactions, and lifts approval…
TRIANA Biomedicines, Inc.Series B $120M · 11 mo ago
TRIANA Biomedicines discovers and develops molecular glue therapeutics employing a target first and rational molecular glue discovery…

Financials

Total raised
$250k
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $250k Details

People

Paul Castella
Executive Officer, Director
Bryan Daniels
Director
Kristen Parker
Director
Kevin Meehan
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Antonio United States
HQ